Accepted (ET)
4:51 PM
Nov 13, 2026
Filed
Nov 13, 2026
Documents
10
Size
722.1 KB
Summary
Cerenome, Inc.: reports Q3 2026 results
What happened
- On Nov 13, 2026, Cerenome, Inc. reported financial results for the third quarter ended Sep 30, 2026 and provided other recent corporate updates. The filing states a copy of the press release is furnished as Exhibit 99.1 to the report and is incorporated by reference.
Key details
- Reported financial results cover the quarter ended Sep 30, 2026.
- The press release announcing the results is furnished as Exhibit 99.1 to the Form 8-K.
- The Form 8-K is signed by Marc H. Hedrick, M.D., President and Chief Executive Officer, dated Nov 13, 2026.
Why it may matter
- The filing reports Item 2.02 (results of operations and financial condition), which covers the company reporting its recent financial results and related corporate updates; Exhibit 99.1 contains the press release. This filing does not show why the insider traded or why the company acted.